A detailed history of Knoll Capital Management, LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Knoll Capital Management, LLC holds 5,574,687 shares of APLT stock, worth $53.7 Million. This represents 23.38% of its overall portfolio holdings.

Number of Shares
5,574,687
Previous 5,574,687 -0.0%
Holding current value
$53.7 Million
Previous $26 Million 82.02%
% of portfolio
23.38%
Previous 17.59%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.25 - $7.4 $225,000 - $740,000
100,000 Added 1.83%
5,574,687 $37.9 Million
Q4 2023

Feb 14, 2024

BUY
$1.84 - $3.35 $575,182 - $1.05 Million
312,599 Added 6.06%
5,474,687 $18.3 Million
Q3 2023

Nov 14, 2023

BUY
$1.26 - $2.77 $2.16 Million - $4.74 Million
1,712,088 Added 49.63%
5,162,088 $12.9 Million
Q1 2023

May 15, 2023

BUY
$0.75 - $1.21 $750,000 - $1.21 Million
1,000,000 Added 40.82%
3,450,000 $2.79 Million
Q4 2022

Feb 14, 2023

BUY
$0.54 - $1.12 $738,653 - $1.53 Million
1,367,877 Added 126.41%
2,450,000 $1.86 Million
Q1 2022

May 16, 2022

BUY
$1.48 - $6.22 $74,000 - $311,000
50,000 Added 4.84%
1,082,123 $2.28 Million
Q2 2021

Aug 16, 2021

BUY
$14.05 - $25.04 $93,558 - $166,741
6,659 Added 0.65%
1,032,123 $21.4 Million
Q1 2021

Jun 14, 2021

BUY
$16.57 - $28.65 $2.88 Million - $4.98 Million
173,913 Added 20.42%
1,025,464 $19.2 Million
Q4 2020

Feb 16, 2021

BUY
$15.44 - $24.23 $1.8 Million - $2.82 Million
116,571 Added 15.86%
851,551 $18.8 Million
Q3 2020

Nov 16, 2020

BUY
$19.43 - $35.36 $1.65 Million - $3 Million
84,742 Added 13.03%
734,980 $15.3 Million
Q2 2020

Aug 14, 2020

BUY
$29.41 - $51.23 $240,191 - $418,395
8,167 Added 1.27%
650,238 $23 Million
Q1 2020

May 15, 2020

BUY
$19.54 - $55.47 $3.42 Million - $9.71 Million
175,000 Added 37.47%
642,071 $21 Million
Q2 2019

Aug 14, 2019

BUY
$8.1 - $10.05 $3.78 Million - $4.69 Million
467,071 New
467,071 $3.85 Million

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $462M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Knoll Capital Management, LLC Portfolio

Follow Knoll Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knoll Capital Management, LLC with notifications on news.